Koyfin Home > Directory > Health Care > Aerie Pharmaceuticals > Long-Term Investments

Aerie Pharmaceuticals Long-Term Investments Chart (AERI)

Aerie Pharmaceuticals annual/quarterly Long-Term Investments from 2014 to 2019.
  • Aerie Pharmaceuticals Long-Term Investments for the quarter ending September 09, 2019 was $5m a -1.69% decrease of 0m year over year
  • Aerie Pharmaceuticals Long-Term Investments for the last 12 months ending September 09, 2019 was $5m a -1.69% decrease of 0m year over year
  • Aerie Pharmaceuticals Annual Long-Term Investments for 2015 was $14m a -32.35% decrease of -4m from 2014
  • Aerie Pharmaceuticals Annual Long-Term Investments for 2014 was $18m
Other Cash Flow Metrics:
  • Aerie Pharmaceuticals Cash Flow from Operations for the quarter ending September 09, 2018 was $-43m a 39.56% decrease of -17m year over year
  • Aerie Pharmaceuticals Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-29m a -53.21% increase of 16m year over year
  • Aerie Pharmaceuticals Total Revenue for the quarter ending September 09, 2018 was $7m
View Chart On Koyfin

Quarterly AERI Long-Term Investments Data

09/2019$5m
09/2017$1m
09/2016$2m
06/2016$5m
03/2016$11m
12/2015$14m
09/2015$8m
06/2015$4m
03/2015$10m
12/2014$18m

Annual AERI Long-Term Investments Data

2015$14m
2014$18m